A former Harvard scientist, who was convicted in the United States for lying to American authorities about payments from China, has rebuilt a high-level brain-computer interface research laboratory in China.
The 67-year-old American scientist was found guilty of lying to authorities about his links to China’s state program to recruit foreign talent and spent two days in prison and six months under house arrest.
Scientist Charles Lieber, once a prominent nanoscience researcher at Harvard University, now leads the Chinese state-backed i-BRAIN initiative in Shenzhen.
Lieber’s return to active research marks a dramatic turnaround for a figure once considered one of the world’s greatest minds in nanoscale science.
In China, he now oversees work on brain-computer interface (BCI) system technology designed to translate brain activity into digital commands that can control external devices such as robotic systems or computers. His work has reignited the global debate about how advanced neurotechnologies could play a role in the future of medicine and warfare.
According to the project description, the lab is developing advanced, non-invasive neural interface systems aimed at enabling communication between the human brain and machines.
This research is part of China’s broader efforts to become a global leader in next-generation neurotechnologies.
China has already elevated brain-computer interfaces to a national strategic priority, with government-backed institutions investing heavily in the field and pushing for rapid commercialization.
Some trials in the country are exploring how BCIs could help paralyzed patients regain movement, while others are looking at broader human-machine interaction systems.
Lieber’s lab operates within the Shenzhen Medical Research and Translation Academy, where he has access to advanced nanofabrication tools and specialized research infrastructure. Chinese officials have positioned the facility as part of a broader effort to attract the world’s top scientific talent to strategic technology sectors.
The development also comes amid growing competition between the United States and China over advanced technologies, including artificial intelligence, quantum systems and neuroengineering. U.S. officials have already warned that such technologies could have dual-use implications, spanning both civilian health care and military modernization.
Lieber has not commented publicly in detail on his new role, but has previously said his scientific goal is to advance cutting-edge research in brain interfaces and nanotechnology.
